Stierle Andrea A, Stierle Donald B, Decato Daniel, Priestley Nigel D, Alverson Jeremy B, Hoody John, McGrath Kelly, Klepacki Dorota
Center for Biomolecular Sciences, College of Pharmacy, University of Illinois at Chicago , Chicago, Illinois 60607, United States.
J Nat Prod. 2017 Apr 28;80(4):1150-1160. doi: 10.1021/acs.jnatprod.7b00133. Epub 2017 Mar 22.
A carefully timed coculture fermentation of Penicillium fuscum and P. camembertii/clavigerum yielded eight new 16-membered-ring macrolides, berkeleylactones A-H (1, 4, 6-9, 12, 13), as well as the known antibiotic macrolide A26771B (5), patulin, and citrinin. There was no evidence of the production of the berkeleylactones or A26771B (5) by either fungus when grown as axenic cultures. The structures were deduced from analyses of spectral data, and the absolute configurations of compounds 1 and 9 were determined by single-crystal X-ray crystallography. Berkeleylactone A (1) exhibited the most potent antimicrobial activity of the macrolide series, with low micromolar activity (MIC = 1-2 μg/mL) against four MRSA strains, as well as Bacillus anthracis, Streptococcus pyogenes, Candida albicans, and Candida glabrata. Mode of action studies have shown that, unlike other macrolide antibiotics, berkeleylactone A (1) does not inhibit protein synthesis nor target the ribosome, which suggests a novel mode of action for its antibiotic activity.
对暗绿青霉和卡门柏青霉/棒形青霉进行精心定时的共培养发酵,得到了8种新的16元大环内酯类化合物,即伯克利内酯A - H(1、4、6 - 9、12、13),以及已知的抗生素大环内酯A26771B(5)、展青霉素和桔霉素。当两种真菌作为无菌培养物生长时,没有证据表明它们会产生伯克利内酯或A26771B(5)。通过光谱数据分析推导了这些化合物的结构,并通过单晶X射线晶体学确定了化合物1和9的绝对构型。伯克利内酯A(1)表现出该系列大环内酯中最强的抗菌活性,对四种耐甲氧西林金黄色葡萄球菌菌株以及炭疽芽孢杆菌、化脓性链球菌、白色念珠菌和光滑念珠菌具有低微摩尔活性(MIC = 1 - 2 μg/mL)。作用机制研究表明,与其他大环内酯类抗生素不同,伯克利内酯A(1)不抑制蛋白质合成,也不以核糖体为靶点,这表明其抗生素活性具有一种新的作用模式。